S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
The How and Why of Investing in Gold Stocks
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
US inflation slows from a 40-year peak but remains high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
The How and Why of Investing in Gold Stocks
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
US inflation slows from a 40-year peak but remains high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
The How and Why of Investing in Gold Stocks
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
US inflation slows from a 40-year peak but remains high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
The How and Why of Investing in Gold Stocks
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
US inflation slows from a 40-year peak but remains high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
NASDAQ:NVIV

InVivo Therapeutics - NVIV Earnings Date, Estimates & Call Transcripts

$7.59
-0.86 (-10.18%)
(As of 08/10/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.04
$8.37
50-Day Range
$3.75
$8.96
52-Week Range
$3.50
$20.23
Volume
128,548 shs
Average Volume
2.14 million shs
Market Capitalization
$10.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data

NVIV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVIV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NVIV Earnings Date and Information

InVivo Therapeutics last posted its earnings data on May 10th, 2022. The biotechnology company reported ($1.94) earnings per share for the quarter. InVivo Therapeutics has generated ($7.69) earnings per share over the last year (($7.69) diluted earnings per share). InVivo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 12th, 2022 based off prior year's report dates.

InVivo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2022
(Estimated)
        
5/10/2022Q1 2022($1.94)($1.94)($1.94)
3/7/2022Q4 2021($2.25)($2.25)($2.25)
11/10/2021Q3 2021($1.75)($1.75)($0.07)
8/13/2021Q2 2021($1.75)($1.75)($0.07)
5/10/2021Q1 2021($2.00)($2.00)($0.08)
11/6/2020Q3 2020($11.75)($11.75)($0.47)
8/11/2020Q2 2020($12.25)($12.25)($0.49)
5/13/2020Q1 2020($61.75)($61.75)($2.47)
11/7/2019Q3 2019($217.50)($217.50)($0.29)
8/13/2019Q2 2019($255.00)($255.00)($0.34)
5/10/2019Q1 2019($210.00)($210.00)($0.28)
11/8/2018Q3 2018($315.00)($315.00)($0.42)
8/7/2018Q2 2018($307.50)($5,610.00)($5,302.50)($7.48)
5/7/2018Q1 2018($2,437.50)($2,505.00)($67.50)($3.34)
3/12/2018Q4 2017($3,000.00)($2,437.50)+$562.50($0.13)
10/30/2017Q3 2017($4,125.00)($5,250.00)($1,125.00)($0.28)
8/8/2017Q2 2017($3,937.50)($3,750.00)+$187.50($0.20)
5/4/2017Q1 2017($4,125.00)($3,750.00)+$375.00($0.20)
3/10/2017Q4 2016($3,750.00)($3,937.50)($187.50)($0.25)
11/4/2016Q3($3,750.00)($3,375.00)+$375.00($0.19)
8/4/2016Q2($4,125.00)($3,375.00)+$750.00($0.20)
5/6/2016Q1 2016($4,875.00)($3,750.00)+$1,125.00($0.16)
3/4/2016Q4 2015($4,125.00)($3,562.50)+$562.50($0.21)
11/4/2015Q3 2015($3,750.00)($4,125.00)($375.00)($0.35)
8/5/2015Q2 2015($3,375.00)($3,937.50)($562.50)($0.03)
5/7/2015Q1 2015($2,062.50)($4,125.00)($2,062.50)$0.20
3/11/2015Q4 2014($4,500.00)($3,000.00)+$1,500.00$0.04
11/5/2014Q3 2014($4,500.00)($3,000.00)+$1,500.00($0.28)
8/6/2014Q2 2014($4,500.00)($3,750.00)+$750.00($0.24)
5/12/2014Q1 2014($6,000.00)($5,250.00)+$750.00($0.28)
3/17/2014Q4 2013($6,000.00)($5,250.00)+$750.00($7.27)
11/7/2013Q3 2013($5,250.00)($5,250.00)($0.28)
8/7/2013Q2 2013($5,250.00)($6,000.00)($750.00)$0.16
5/9/2013Q1 2013($6,000.00)($3,000.00)+$3,000.00$0.48
3/13/2013Q4 2012($4,500.00)($5,250.00)($750.00)($0.04)
11/14/2012Q3 2012($4,500.00)($3,000.00)+$1,500.00($0.76)
8/14/2012Q2 2012($4,500.00)($2,812.50)+$1,687.50($0.42)
5/15/2012Q1 2012($1,500.00)($3,375.00)($1,875.00)($0.54)
3/15/2012Q4 2011($3,000.00)($3,750.00)($750.00)$2.32
11/15/2011Q3 2011($3,000.00)($3,000.00)($0.55)
8/11/2011Q2 2011($2,250.00)($3,750.00)($1,500.00)($0.29)












InVivo Therapeutics Earnings - Frequently Asked Questions

When is InVivo Therapeutics's earnings date?

InVivo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 12th, 2022 based off last year's report dates. Learn more on NVIV's earnings history.

How much profit does InVivo Therapeutics generate each year?

InVivo Therapeutics (NASDAQ:NVIV) has a recorded net income of -$9.90 million. NVIV has generated -$7.69 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:NVIV) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.